Retinol lotion reduces the fine wrinkles from natural aging of skin
...ng. The lotion was made at U-M, but U-M will not commercialize this lotion because it was designed only for experimental purposes and, therefore, is cosmetically undesirable. Many retinol containing cosmeceutical creams, however, are sold by various companies. Those specific products were not tested by the U-M t...New biotech company to commercialize novel UD gene-repair technology
... has been established in Wilmington to develop and commercialize UD-patented technologies for repairing genes that cause rare, hereditary diseases such as sickle cell anemia and spinal muscular atrophy. The announcement was made in a news release issued by the company on April 13. Eric Kmiec, professor of biol...LIALDA -- the first oral once-daily mesalamine for ulcerative colitis -- now available
...m Giuliani SpA the exclusive rights to develop and commercialize LIALDA in the U.S., Canada, Europe -- known as MEZAVANT -- (excluding Italy) and the Pacific Rim. Giuliani SpA retains the development and commercialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the MMX technology. LIALDA Ef...Probe to detect spread of breast cancer co-developed by UH scientist
...ity at UH (TcSUH), said a goal of the grant was to commercialize biomedical technology developed at universities through collaborative research. He and Pankhurst, deputy director of the London Centre for Nanotechnology, have formed a medical devices company Endomagnetics Inc. to bring their technology to the ma...Inexpensive test detects H5N1 infections quickly and accurately
... Dr. Rowlen says, and discussions are under way to commercialize its manufacture....Lisdexamfetamine dimesylate in ADHD phase 3 data presented
... collaborative agreement with Shire to develop and commercialize lisdexamfetamine dimesylate (NRP104/LDX). New River received an approvable letter from the U.S. Food and Drug Administration (FDA) for lisdexamfetamine dimesylate (NRP104/LDX) on October 6, 2006. According to the FDA's letter, marketing approval is...University of Rochester spin-off secures $2 million in funding
...ogies, Inc., a company formed earlier this year to commercialize leading cardiac safety technologies developed at t...nt with the University of Rochester to license and commercialize technology and unique biomarkers that enable pharmaceutical companies to more effectively determine ...SWAN system to help blind and firefighters navigate environment
...ion of a park in the distance. There are plans to commercialize the SWAN technology after further refinement, testing and miniaturizing of components for the consumer market....Abuse liability study results of lisdexamfetamine dimesylate (NRP104) presented at CPDD
... collaborative agreement with Shire to develop and commercialize the product and on December 6, 2005, filed a New Drug Application with the U.S. Food and Drug Administration to evaluate lisdexamfetamine dimesylate for the treatment of ADHD. This application is currently under review. Results of "Pharmacokinet...Stevens in agreement with Competitive Technologies to commercialize Stevens' IP worldwide
... with CompetitiveTechnologies, Inc. (AMEX: CTT) to commercialize some of Stevens'intellectual property on a worldwide basis. Dr. Helena S. Wisniewski, Vice President, University Research and Enterprise Development for Stevens, said, "We look forward to a growing relationship with CTT. Stevens' rich IP portfolio...New technology detects risks of drugs to heart sooner
...logies, Inc. have signed an exclusive agreement to commercialize software developed by biomedical engineer Jean-Philippe Couderc, Ph.D., that provides a more accurate and reliable method to analyze data from electrocardiograms (ECG) and other types of heart monitors to determine whether a drug is toxic to the hear...NRP104 significantly reduced symptoms of attention deficit hyperactivity disorder in children
... collaborative agreement with Shire to develop and commercialize the product. On December 6, 2005 New River filed a New Drug Application with U.S. Food and Drug Administration to evaluate NRP104 for the treatment of ADHD. This application is currently under review. Phase III Study Results of NRP104 In the ph...Novel device shows potential in better detecting oral cancer
...losely with a corporate partner that would like to commercialize the VELScope. "The box was molded into the lightweight, hand-held structure, a flexible cord attaches the examination light, and the goggles became the view finder that allows dentists to directly evaluate lesions in real time." In their study, the ...PlasmaSol, Stevens spin-out, acquired for $17.5 million
... students joined together and founded a company to commercialize a patented environmental technology invented at th...uate students from Stevens co-founded PlasmaSol to commercialize the non-thermal plasma technology: Kurt Kovach, Seth A. Tropper, and Richard Crowe, with the later a...Molecular Profiling Institute secures $7.5 million in Series B funding
...aboration with Molecular Profiling to validate and commercialize certain of its investigational assays. The first will be the investigational PCA3 test, which is intended as an aid in the diagnosis of prostate cancer. Henry L. Nordhoff, Chairman, President and CEO of Gen-Probe stated that "Molecular Profiling h...Beating the aging process naturally
...nc, a spin-off company formed in the late 1980s to commercialize technology from the University of Alberta's faculties of pharmacy and medicine for the treatment of cold sores. Beta-glucan is the soluble fiber found in the cell walls of oat kernels. Oat has a long history of safe use in providing fast, temporary r...MCW Research Foundation licenses invention for stroke treatment
...xclusive, world-wide rights to further develop and commercialize the drug. Dr. Roman, director of the Medical Col...ollege and licenses it in line with its mission to commercialize as many inventions as possible to help patients. The Foundation believes that its "Patents to Patie...NIH awards funding to biotech firm for heart disease
...s of Ohio that it would develop new technology and commercialize it. Arteriocyte represents the first installment on that promise."......moScience GmbH of Aachen, Germany was developed to commercialize the discovery. "Now instead of heat , we can induce the shape-memory effect in polymers with light," said Lendlein. Key to the work: "molecular switches," or photosensitive groups that are grafted onto a permanent polymer network. The resulting photo...